Drug Trial Radar · NCT02042183
Lubiprostone in Children With Functional Constipation
Last checked: Nov 19, 2026Latest source record: Jul 21, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
606
Actual
Start
Dec 13, 2013
Primary completion
Jul 27, 2016
Study completion Jul 27, 2016
Sponsor
- Lead sponsor
- Sucampo Pharma Americas, LLCIndustry
- Sponsor type
- Industry
- Collaborators
- Sucampo AG
- First posted
- Jan 22, 2014
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 6 years, up to 17 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Study to determine if children (6-17 years old) with functional constipation will respond to being treated with lubiprostone for 12 weeks.
Conditions
- Constipation - Functional
Interventions
LubiprostoneDrug
12 or 24 mcg soft capsules of lubiprostone for oral administration, depending on baseline weight and response during week 1
PlaceboDrug
0 mcg soft capsules of placebo for oral administration
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants Classified as Overall Responders at Week 12Time frame: at Week 12
Locations
117 sites in 7 countries. Site status is shown where the registry gives one.
University of Alabama Pediatric Gastroenterology
Birmingham, Alabama
University of South Alabama Women's and Children's Hospital
Mobile, Alabama
Arizona Children's Center at Maricopa Medical Center
Phoenix, Arizona
Phoenix Children's Hospital
Phoenix, Arizona
Northwest Arkansas Pediatric Clinic
Fayetteville, Arkansas
Arkansas Children's Hospital Research Institute
Little Rock, Arkansas
Applied Clinical Research of Arkansas
Little Rock, Arkansas
WCCT Global
Costa Mesa, California
Loma Linda University Health Care
Loma Linda, California
Children's Hospital Los Angeles
Los Angeles, California
Children's Hospital of Orange County
Orange, California
University of California, San Francisco
San Francisco, California
MCB Clinical Research
Colorado Springs, Colorado
Nemours/Alfred I. duPont Hospital for Children
Wilmington, Delaware
Emmerson Clinical Research
Washington D.C., District of Columbia
University of Florida
Gainesville, Florida
Palmetto Professional Research
Hialeah, Florida
Nemours Children's Clinic
Jacksonville, Florida
Acevedo Clinical Research Associates
Miami, Florida
Savin Medical Group Research Center
Miami Lakes, Florida
Digestive & Liver Center of Florida
Orlando, Florida
Nemours Childrens Clinic
Pensacola, Florida
Children's Center for Digestive Healthcare/GI Care for Kids
Atlanta, Georgia
Center For Children's Digestive Health
Park Ridge, Illinois
Methodist Medical Center
Peoria, Illinois
PediaResearch, LLC - Newburgh
Newburgh, Indiana
UnityPoint Health Des Moines/ Blank Children's Clinic
Des Moines, Iowa
University of Iowa Children's Hospital
Iowa City, Iowa
Heartland Research Associates
Wichita, Kansas
University of Louisville Research Foundation Inc. Kosair Charities Pediatric Clinical Research Unit
Louisville, Kentucky
PediaResearch, LLC - Owensboro
Owensboro, Kentucky
Children's Hospital
New Orleans, Louisiana
Willis-Knighton Physician Network
Shreveport, Louisiana
Johns Hopkins Children's Center
Baltimore, Maryland
Virgo-Carter Pediatrics
Silver Spring, Maryland
Boston Children's Hospital
Boston, Massachusetts
Mayo Clinic
Rochester, Minnesota
Gastrointestinal Associates, PA
Jackson, Mississippi
University of Mississippi Medical Center
Jackson, Mississippi
The Children's Mercy Hospital
Kansas City, Missouri
Showing 40 of 117 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.